A series of bifunctional pyridine-aminopyrimidine/aminopyridine supramolecular reagents (SRs) have been synthesized through palladium-catalyzed cross-coupling reactions and characterized by single-crystal X-ray crystallography. 3-(2-Amino-4-methylpyrimidin-6-yl)pyridine 1, 4-(2-amino-4-methylpyrimidin-6-yl)pyridine 2, and 4-methoxy-3-(2-amino-4-methylpyrimidin-6-yl)pyridine 3 were synthesized via Suzuki-Miyaura cross-coupling conditions in good yields, whereas 1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne 4, 1-(2-aminopyrid-5-yl)-2-(pyrid-3-yl)ethyne 5, and 1-(6-amino-3-pyridyl)-2-(4-{benzimidazol-1-yl}phenyl)ethyne 6 were synthesized through conventional Sonogashira cross-coupling conditions. The primary hydrogen-bonding motif in solid-state structures 1 – 5 is a self-complementary amino-pyrimidine N–H···N/N···H–N synthon, whereas adjacent molecules in the structure of 6 are connected via aminopyridine-benzimidazole N–H···N hydrogen bonds. Secondary anti -amino proton/pyridyl N–H···N hydrogen bonds exist in the structures of 1, 2, 4, and 5, thereby establishing a hierarchy of intermolecular interactions in structures with multiple hydrogen-bond donors and acceptors.
No takes yet. Share an insight, caveat, or question.
Aakeröy et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: